» Articles » PMID: 22659989

Survival Benefits of Metabolic Syndrome Among Older Men Aged 75 Years and over in Taiwan

Overview
Date 2012 Jun 5
PMID 22659989
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic syndrome (MetS) was common in the elderly, but its prognostic significance in older old population remained unclear. The main purpose of this study was to evaluate the survival impact of MetS among older men aged 75 and over in Taiwan.

Methods: From 2008, residents aged 75 years and older of Banciao Veterans Home were invited for study and were followed for 3 years. All participants received history taking, physical examinations, and laboratory tests. Mortality was determined by Veteran Affairs Death Registry, which was linked to the National Death Registry.

Results: Overall, 680 men (mean age: 82.5±4.7 years) were enrolled for study and the prevalence of MetS was 31.6%. During the follow-up period, 140 (20.6%) participants died, and the causes of death included infectious diseases (62, 9.1%), cardiovascular disease (37, 5.4%), cancer (20, 2.9%), and others (21, 3.1%). MetS subjects had a significantly higher prevalence of hypertension, diabetes mellitus, and having higher body mass index, waist circumferences, systolic blood pressure, fasting blood glucose, serum triglyceride and lower HDL-C level than non-MetS subjects. However, MetS subjects were less likely to die during study period (16.3% vs. 22.6%, P=0.059). Multivariate logistic regression showed that older age (OR:1.04, 95% C.I.: 1.00-1.08, P=0.04), diabetes mellitus (OR: 2.10, 95% CI: 1.34-3.30, P=0.001) were independent risk factors for mortality; and serum total cholesterol and triglyceride were protective factors (OR: 0.99, 95% CI: 0.99-1.00, P=0.037 for cholesterol; OR: 0.99, 95% CI: 0.99-1.00, P=0.013 for triglyceride). Adjusted for age, diabetes mellitus, serum levels of total cholesterol, and triglyceride, MetS played a potential trend of survival benefits among study subjects (HR: 0.71, 95% CI: 0.45-1.12, P=0.144).

Conclusions: The prevalence of MetS among men aged 75 years and over was 31.6%, and the 3-year mortality rate was 20.6%. Older age, diabetes mellitus, lower serum cholesterol and lower serum triglyceride were independent risk factors for mortality. Further investigation is needed to clarify the prognostic impact of MetS in older adults.

Citing Articles

Identification of a Link between Suspected Metabolic Syndrome and Cognitive Impairment within Pharmaceutical Care in Adults over 75 Years of Age.

Macekova Z, Fazekas T, Krivosova M, Dragasek J, Zufkova V, Klimas J Healthcare (Basel). 2023; 11(5).

PMID: 36900723 PMC: 10000537. DOI: 10.3390/healthcare11050718.


Association of Metabolic Syndrome and Its Components with Survival of Older Adults.

Bijani A, Hosseini S, Ghadimi R, Mouodi S Int J Endocrinol Metab. 2020; 18(1):e91837.

PMID: 32308697 PMC: 7144244. DOI: 10.5812/ijem.91837.


Frequency of metabolic syndrome and associated factors in institutionalized elderly individuals.

Sales M, Oliveira L, Pereira Liberalino L, Cunha A, Sousa S, Lemos T Clin Interv Aging. 2018; 13:2453-2464.

PMID: 30555225 PMC: 6280900. DOI: 10.2147/CIA.S177731.


Effect of Body Weight, Waist Circumference and Their Changes on Mortality: a 10-Year Population-based Study.

Lee W, Peng L, Loh C, Chen L J Nutr Health Aging. 2018; 22(8):959-964.

PMID: 30272100 DOI: 10.1007/s12603-018-1042-4.


Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A meta-analysis of prospective cohort studies.

Ju S, Lee J, Kim D Medicine (Baltimore). 2017; 96(45):e8491.

PMID: 29137039 PMC: 5690732. DOI: 10.1097/MD.0000000000008491.


References
1.
Akbaraly T, Kivimaki M, Ancelin M, Barberger-Gateau P, Mura T, Tzourio C . Metabolic syndrome, its components, and mortality in the elderly. J Clin Endocrinol Metab. 2010; 95(11):E327-32. PMC: 2968732. DOI: 10.1210/jc.2010-0153. View

2.
Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F . Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006; 29(11):2471-6. DOI: 10.2337/dc06-0282. View

3.
Cameron A, Shaw J, Zimmet P . The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004; 33(2):351-75, table of contents. DOI: 10.1016/j.ecl.2004.03.005. View

4.
Chen Y, Hwang S, Chen L, Chen D, Lan C . Risk factors for falls among elderly men in a veterans home. J Chin Med Assoc. 2008; 71(4):180-5. DOI: 10.1016/S1726-4901(08)70101-1. View

5.
Khang Y, Cho S, Kim H . Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis. 2010; 213(2):579-85. DOI: 10.1016/j.atherosclerosis.2010.09.009. View